ConductScience.org, home

Paper4810941

Antibacterial activity in serum and urine as a therapeutic guide in bacterial infections.

Klastersky J and 3 others. J Infect Dis, 1974. Cited by 264 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Antibacterial activity in serum and urine as a therapeutic guide in bacterial infections. Papers, record 4810941. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4810941

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antibacterial activity in serum and urine as a therapeutic guide in bacterial infections.
PubMed
Journal
J Infect Dis
PubMed
Year
1974
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
264
iCite
Relative citation ratio, by iCite
14.2
iCite
Revised in PubMed
2019-05-11
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Klastersky JJ
2Daneau DD
3Swings GG
4Weerts DD

Source PubMed

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
Bacterial InfectionsMajor topic
Blood Bactericidal ActivityMajor topic
Carbenicillin
Cephalexin
Cephalothin
Doxycycline
Drug Therapy, Combination
Gentamicins
Humans
Respiratory Tract Infections
Sepsis
Urinary Tract Infections
Wound Infection

Source PubMed

Cited by86

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 264 citations.

PMIDTitleJournalYearIn PapersSource
34,435,316Potential Antibiotics for the Treatment of Neonatal Sepsis Caused by Multidrug-Resistant Bacteria.Paediatr Drugs2021https://conductscience.org/library/papers/34435316PubMed
23,960,738Once versus individualized multiple daily dosing of aminoglycosides in critically ill patients.Saudi Pharm J2011https://conductscience.org/library/papers/23960738PubMed
22,162,703Polymyxin Combination Therapy and the Use of Serum Bactericidal Titers in the Management of KPC-Producing Klebsiella pneumoniae Infections: A Report of 3 Cases.Case Rep Med2011https://conductscience.org/library/papers/22162703PubMed
11,353,641Antibacterial properties of gemifloxacin and trovafloxacin in urine ex vivo: phase I study.Antimicrob Agents Chemother2001https://conductscience.org/library/papers/11353641PubMed
11,083,664Levofloxacin pharmacokinetics and serum bactericidal activities against five enterobacterial species.Antimicrob Agents Chemother2000https://conductscience.org/library/papers/11083664PubMed
10,554,046Basis of anti-infective therapy: pharmacokinetic-pharmacodynamic criteria and methodology for dual dosage individualisation.Clin Pharmacokinet1999https://conductscience.org/library/papers/10554046PubMed
10,146,940Pharmacoeconomics of intravenous drug administration.Pharmacoeconomics1992https://conductscience.org/library/papers/10146940PubMed
10,049,277Optimizing aminoglycoside therapy for nosocomial pneumonia caused by gram-negative bacteria.Antimicrob Agents Chemother1999https://conductscience.org/library/papers/10049277PubMed
9,661,031
Dosing of aminoglycosides to rapidly attain pharmacodynamic goals and hasten therapeutic response by using individualized pharmacokinetic monitoring of patients with pneumonia caused by gram-negative organisms.
Antimicrob Agents Chemother1998https://conductscience.org/library/papers/9661031PubMed
9,174,206Pharmacodynamic effects of amoxicillin versus cefotaxime against penicillin-susceptible and penicillin-resistant pneumococcal strains: a phase I study.Antimicrob Agents Chemother1997https://conductscience.org/library/papers/9174206PubMed
9,145,846Suspicion of quinolone active metabolite following discrepancy between predicted and experimental urine bactericidal activities.Antimicrob Agents Chemother1997https://conductscience.org/library/papers/9145846PubMed
8,851,610Pharmacokinetics of sparfloxacin and serum bactericidal activity against pneumococci.Antimicrob Agents Chemother1996https://conductscience.org/library/papers/8851610PubMed
8,834,888Single-dose rufloxacin versus 3-day norfloxacin treatment of uncomplicated cystitis: clinical evaluation and pharmacodynamic considerations.Antimicrob Agents Chemother1996https://conductscience.org/library/papers/8834888PubMed
8,787,889Serum bactericidal activities and comparative pharmacokinetics of meropenem and imipenem-cilastatin.Antimicrob Agents Chemother1996https://conductscience.org/library/papers/8787889PubMed
8,787,872Ex vivo antibacterial properties of rufloxacin compared with those of norfloxacin in a study with healthy volunteers.Antimicrob Agents Chemother1996https://conductscience.org/library/papers/8787872PubMed
8,723,449
Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto Infection Program.
Antimicrob Agents Chemother1996https://conductscience.org/library/papers/8723449PubMed
8,239,592Comparative pharmacokinetics and serum bactericidal activities of SCE-2787 and ceftazidime.Antimicrob Agents Chemother1993https://conductscience.org/library/papers/8239592PubMed
8,193,880Double beta-lactam regimen compared to an aminoglycoside/beta-lactam regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.Support Care Cancer1993https://conductscience.org/library/papers/8193880PubMed
7,518,762Comparative pharmacokinetics of the new oral cephalosporins.Drugs1994https://conductscience.org/library/papers/7518762PubMed
7,399,715Basis for an adequate dosage of aminoglycoside antibiotics.Infection1980https://conductscience.org/library/papers/7399715PubMed

See all 86 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4810941

GET https://conductscience.org/api/papers/v1/4810941/cited_by?page=2